Publicaciones

1.Effects of Allicin on Hypertension and Cardiac Function in Chronic Kidney Disease.

García-Trejo EM, Arellano-Buendía AS, Argüello-García R, Loredo-Mendoza ML, García-Arroyo FE, Arellano-Mendoza MG, Castillo-Hernández MC, Guevara-Balcázar G, Tapia E, Sánchez-Lozada LG, Osorio-Alonso H.

Oxid Med Cell Longev. 2016;2016:3850402. Epub 2016 Nov 21.

2. A review of the impact of oxidative stress and some antioxidant therapies on renal damage.

Tamay-Cach F, Quintana-Pérez JC, Trujillo-Ferrara JG, Cuevas-Hernández RI, Del Valle-Mondragón L, García-Trejo EM, Arellano-Mendoza MG.

Ren Fail. 2016;38(2):171-5. doi: 10.3109/0886022X.2015.1120097. Epub 2015 Dec 7.

3. Antioxidative diet supplementation reverses high-fat diet-induced increases of cardiovascular risk factors in mice.

Vargas-Robles H, Rios A, Arellano-Mendoza M, Escalante BA, Schnoor M.

Oxid Med Cell Longev. 2015;2015:467471. doi: 10.1155/2015/467471. Epub 2015 Apr 1.

4.Early stage of obesity potentiates nitric oxide reduction during the development of renal failure.

Gámez-Méndez AM, Vargas-Robles H, Arellano-Mendoza M, Cruz-Laguna E, Rios A, Escalante B.

J Nephrol. 2014 Jan 21. [Epub ahead of print

5. Early stage of obesity potentiates nitric oxide reduction during the development of renal failure.

Gámez-Méndez AM, Vargas-Robles H, Arellano-Mendoza M, Cruz-Laguna E, Rios A, Escalante B.

J Nephrol. 2014 Jun;27(3):281-7. doi: 10.1007/s40620-013-0029-9. Epub 2014 Jan 21.

6. Relationship between angiotensin II receptor expression and cardiovascular risk factors in Mexican patients with coronary occlusive disease.

Baños M, Arellano-Mendoza MG, Vargas-Robles H, Avila-Casado MC, Soto V, Romo E, Rios A, Hernandez-Zavala A, de la Peña-Diaz A, Escalante B.

Exp Mol Pathol. 2011 Aug;91(1):478-83.

7. Prevention of renal injury and endothelial dysfunction by chronic L-arginine and antioxidant treatment.

Arellano-Mendoza MG, Vargas-Robles H, Del Valle-Mondragon L, Rios A, Escalante B.

Ren Fail. 2011;33(1):47-53.

8. L-arginine and antioxidant diet supplementation partially restores nitric oxide-dependent regulation of phenylephrine renal vasoconstriction in diabetics rats.

Coronel I, Arellano-Mendoza MG, del Valle-Mondragon L, Vargas-Robles H, Castorena-Torres F, Romo E, Rios A, Escalante B.

J Ren Nutr. 2010 May;20(3):158-68.
9. Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase -/- mice and improved by combined administration of L-arginine and antioxidants.
Mendoza MG, Castillo-Henkel C, Medina-Santillan R, Jarillo Luna RA, Robles HV, Romo E, Rios A, Escalante B.

Nephrology (Carlton). 2008 Jun;13(3):218-27. doi: 10.1111/j.1440-1797.2007.00897.x

10. Nitric oxide-dependent neovascularization role in the lower extremity disease.

Mendoza MG, Robles HV, Romo E, Rios A, Escalante B.

Curr Pharm Des. 2007;13(35):3591-6. Review.

11. Synthesis, pharmacological and in silico evaluation of 1-(4-di-hydroxy-3,5-dioxa-4-borabicyclo[4.4.0]deca-7,9,11-trien-9-yl)-2-(tert-butylamino)ethanol, a compound designed to act as a beta2 adrenoceptor agonist.

Soriano-Ursúa MA, Valencia-Hernández I, Arellano-Mendoza MG, Correa-Basurto J, Trujillo-Ferrara JG.

Eur J Med Chem. 2009 Jul;44(7):2840-6. doi: 10.1016/j.ejmech.2008.12.016. Epub 2008 Dec 25
12.Effects of supplementation with L-arginine, vitamins C and E, and ω-3 fatty acids on the development of kidney failure in miceMónica Griselda Arellano-Mendoza; Hilda Vargas-Robles; Carlos Castillo-Henkel; Gerardo Reyes; Bruno Escalante-Acosta; Roberto Medina-SantillánProceedings of the Western Pharmacology Society 2006;49():75-76.
113.Supplement with omega-3 fatty acids, L-arginine and antioxidants elements prevent kidney failure development Nutrition and metabolism in renal disease G228C0071 33-37,2006